NCT05463302

Brief Summary

Exposure to electromagnetic field (EMF) emitted by mobile phones and devices with WIFI is on the rise and so is the EMF effects on sleep quality and well-being of individuals with high exposures to EMF. Some studies have shown poor sleep quality among individuals with long-term occupational exposure to EMF, and some have shown association between EMF long-term exposure and neuropsychiatric disorders including depression. This study aims to investigate a commercially available EMF- blocker blanket, called Sleepgift, that claims helping people to have a better sleep and improved health. We will investigate the Sleepgift efficacy on adults' quality of sleep and their vital signals as a measure of their well-being in a placebo-controlled single- blind cross-over designed study. Participants will sleep in our sleep lab at baseline and then 10 days later with the Sleepgift blanket after using it every night for the past 10 consecutive days. Participants will be given two blankets for each cycle of the study as it is a cross-over designed study: one Sleepgift and one regular blanket; they will not know which one is real or sham. There will be one-month washout period between the two cycles of the cross-over study. We aim to enroll 30 adults for the study. Participants' sleep quality will be measured by the established device called Prodogy; their vital signals will also be measured and monitored through the night. The collected data will be analyzed statistically for any significant effect of the Sleepgift blanket on sleep quality and vital signals such as heart's rhythm and heart rate variability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P50-P75 for early_phase_1

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 12, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 11, 2024

Completed
Last Updated

April 3, 2025

Status Verified

December 1, 2023

Enrollment Period

1.8 years

First QC Date

July 12, 2022

Last Update Submit

March 31, 2025

Conditions

Keywords

electromagnetic field effectsleep qualityEMF blocker

Outcome Measures

Primary Outcomes (1)

  • Sleep quality measure

    The change in the value of Odds of the Product (ORP) from baseline line to post-intervention, measured by the Prodigy device which is a combination of the EEG band waves. ORP is only one value output of the device.

    Through study completion, 2 years approximately

Secondary Outcomes (1)

  • heart rate variability

    Through study completion, 2 years approximately

Study Arms (2)

Active EMF blanket

ACTIVE COMPARATOR

participants will receive the real EMF blocker blanket

Device: Active sleepgift blanketDevice: Sham Sleepgift Blanket

Sham EMF blanket

PLACEBO COMPARATOR

participants will receive the sham EMF blocker blanket

Device: Active sleepgift blanketDevice: Sham Sleepgift Blanket

Interventions

Participants for group1 will be provided with real/active sleepgift blanket first for 10 consecutive nights and then cross over.

Active EMF blanketSham EMF blanket

Participants for group 2 will be provided with sham sleepgift blanket for 10 consecutive nights and then cross over.

Active EMF blanketSham EMF blanket

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • y\<age\<70 years
  • Being generally healthy (cognitively and psychologically)
  • ability to read, write and speak English fluently.

You may not qualify if:

  • Being diagnosed with any neurological, intellectual disability, major depression/anxiety, bipolar disorder, schizophrenia or any other major mood disorder.
  • Inability to adequately communicate in English
  • Current substance abuse disorder
  • Currently participating in another therapeutic study
  • Being on a regular pain killer, sleeping or depression pill.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Riverview Health Center

Winnipeg, Manitoba, R3L 2P4, Canada

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Zahra Moussavi, Ph.D.

    University of Manitoba

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
participants receive two similar blankets, while one of them is real and one is sham but they are blind to which one is which.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: it is two period design with one cross over
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 18, 2022

Study Start

January 1, 2023

Primary Completion

October 11, 2024

Study Completion

October 11, 2024

Last Updated

April 3, 2025

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will share

When the study is finished, de-identified data could be shared publicly by other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After Aug. 2025

Locations